Incidence, Timing and Associated Factors of In-Stent Restenosis after CASPER Placement: A Single-Center Retrospective

Yasutaka Murakami1, Shuta Aketa2, Kenji Fukutome2

  • 1Department of Neurology, Osaka Keisatsu Hospital, Osaka, Osaka, Japan.

Insights

In-stent restenosis (ISR) after CASPER stent placement occurred in 12.5% of patients within 18 months. Lower plaque-to-muscle ratio and smaller stent diameter were linked to ISR development. Further research is needed for long-term outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • The CASPER stent is a dual-layer micromesh device for carotid artery stenting, aiming to reduce stroke risk.
  • In-stent restenosis (ISR) is a known complication of carotid stenting.
  • Data on ISR incidence and risk factors specifically for the CASPER stent in Japan is limited.

Purpose of the Study:

  • To evaluate the incidence and timing of ISR after CASPER stent placement.
  • To identify factors associated with ISR development in patients treated with the CASPER stent.

Main Methods:

  • Retrospective analysis of 80 consecutive patients who underwent CASPER stent placement.
  • Review of preprocedural plaque characteristics (including T1-weighted MRI for plaque-to-muscle ratio - PMR), procedural details, and follow-up carotid ultrasound.
  • ISR defined as luminal narrowing ≥50% (symptomatic) or ≥70% (asymptomatic).

Main Results:

  • ISR occurred in 10 patients (12.5%) over a mean follow-up of 27.6 months, with a median onset of 8.5 months (range 1.8-16.4 months).
  • Patients with ISR had significantly lower PMR values (1.45 vs. 1.90, p=0.024) and smaller stent diameters (median 7.5 vs. 8.0 mm, p=0.029).
  • A trend towards increased ipsilateral ischemic stroke was observed in patients with ISR (20.0% vs. 2.9%, p=0.056).

Conclusions:

  • ISR after CASPER stenting typically occurs within 18 months.
  • Lower plaque-to-muscle ratio and smaller stent diameter are associated with ISR in this cohort.
  • Larger studies are warranted to confirm these findings and assess long-term outcomes of the CASPER stent.
Abstract